Wyss Center and Osypka announce collaboration

Pushing the boundaries of implantable neuro-device development.

Neurotechnology holds promise for chronic stroke patients

Personalized neurotech could boost rehab success.

Dr Mary Tolikas announced as new Director of the Wyss Center

The Executive Board of the Wyss Center for Bio and Neuroengineering has announced that Dr Mary Tolikas will assume responsibility as Executive Director on 1st June 2019, taking over from Professor John Donoghue.

Advances in deep brain stimulation could lead to new treatments for people with movement and psychiatric disorders

Recent advances in DBS could lead to treatments for obsessive-compulsive disorder, Gilles de la Tourette syndrome and depression.

Wyss Center neurologist awarded prestigious Pfizer Research Prize

Maxime Baud, MD, PhD, Staff neurologist at the Wyss Center, and epileptologist at the University of Bern and Geneva University Hospitals (HUG), was awarded the Pfizer Research Prize for his work in the field of neuroscience and nervous system disorders.

Third annual Wyss Investigators Symposium

Wyss Center supported investigators gathered at Campus Biotech on Thursday 6 December 2018 for the third annual Wyss Center Investigators Symposium.

Wyss Center Development Director awarded BioAlps academy prize

Implanted devices could improve epilepsy management

Continuous monitoring of brain activity could improve quality of life for people with epilepsy, say clinicians.

Wyss Center showcases research at La Nuit de la Science

Campus Biotech joined forces with La Nuit de la Science for the first time and welcomed visitors onto campus for the duration of the two-day event.

BioAlps appoints Wyss Center CTO as President

Claude Clément joins Swiss life sciences cluster as President, taking over from Benoît Dubuis.